Literature DB >> 18657044

HTLV type 1 genetic types among native descendants in Argentina.

René Gastaldello1, Alena Mayo Iñiguez, Koko Otsuki, Gabriela Lamas, Marcos Balangero, María Gabriela Barbas, Andrea Mangano, Luisa Sen, Eduardo Maturano, Carlos Remondegui, Ana Carolina Paulo Vicente, Sandra Gallego.   

Abstract

The province of San Salvador de Jujuy, located in the northwest of Argentina, is a highly endemic area for HTLV-1 infection and a foci of tropical spastic paraparesis/HTLV-1-associated myelopathy (HAM/TSP). Therefore, to better understand this, we carried out a genetic characterization of a large set of HTLV-1 strains (n = 65) of descendants of Amerindians from this region. The LTR and env regions were analyzed. The genetic analysis showed that all of these new HTLV-1 isolates from Argentina belong to the Transcontinental subgroup A of the HTLV-1a Cosmopolitan subtype, with the exception of three isolates that cluster within the Japanese subgroup B. Interestingly, the majority of the sequences from Jujuy province belonged to a distinct cluster within the Latin America Transcontinental subgroup, referred to here as the Jujuy subcluster, and were characterized by specific signatures in the LTR. Given that the samples analyzed in this study belong to the Amerindian population and the high prevalence of HTLV-1 in Jujuy in contrast to the low prevalence of this virus in the country, it could be that HTLV-1aA was spread in Argentina from the Amerindians to the cosmopolitan population. Moreover, this is the first report of an HTLV-1aB or Japanese subgroup in descendants of non-Japanese people in South America.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657044     DOI: 10.1089/aid.2007.0299

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  An overview of sequencing technology platforms applied to HTLV-1 studies: a systematic review.

Authors:  Felipe de Oliveira Andrade; Marina Silveira Cucco; Melina Mosquera Navarro Borba; Reinaldo Conceição Neto; Luana Leandro Gois; Filipe Ferreira de Almeida Rego; Luciane Amorim Santos; Fernanda Khouri Barreto
Journal:  Arch Virol       Date:  2021-08-20       Impact factor: 2.574

2.  IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.

Authors:  Ivan Best; Giovanni López; Kristien Verdonck; Elsa González; Martín Tipismana; Eduardo Gotuzzo; Guido Vanham; Daniel Clark
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

3.  Genetic characterization of human T-cell lymphotropic virus type 1 in Mozambique: transcontinental lineages drive the HTLV-1 endemic.

Authors:  Ana Carolina P Vicente; Eduardo Samo Gudo; Alena Mayo Iñiguez; Koko Otsuki; Nilesh Bhatt; Celina M Abreu; Adolfo Vubil; Dulce Bila; Orlando C Ferreira; Amílcar Tanuri; Ilesh V Jani
Journal:  PLoS Negl Trop Dis       Date:  2011-04-12

4.  Silent dissemination of HTLV-1 in an endemic area of Argentina. Epidemiological and molecular evidence of intrafamilial transmission.

Authors:  María C Frutos; Rene Gastaldello; Marcos Balangero; Carlos Remondegui; Sebastián Blanco; Koko Otsuki; Ana Carolina Paulo Vicente; David Elías; Arnaldo Mangeaud; Silvia Nates; Sandra Gallego
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

Review 5.  Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes.

Authors:  Philippe V Afonso; Olivier Cassar; Antoine Gessain
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

6.  Association between HLA Class I Alleles and Proviral Load in HTLV-I Associated Myelopathy/Tropical Spastic Paraperesis (HAM/TSP) Patients in Iranian Population.

Authors:  Mahdi Taghaddosi; S A Rahim Rezaee; Houshang Rafatpanah; Taraneh Rajaei; Reza Farid Hosseini; Valizadeh Narges
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.